Chemical Compound
[2aR-[2a?,4?,4a?,6?,9?(?R*,?S*),11?,12?,12a?,12b?]]-?-(Benzoylamino)-?-hydroxy-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester benzenepropanoic acid
CAS Registry Number
33069-62-4
Primary record
[2aR-[2a?,4?,4a?,6?,9?(?R*,?S*),11?,12?,12a?,12b?]]-?-(Benzoylamino)-?-hydroxy-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester benzenepropanoic acid
- 库存
- 6,094 克
- 纯度
- 98.1 %
- CAS
- 33069-62-4
化合物标识与属性
- CAS
- 33069-62-4
- PubChem CID
- 441276
- SMILES
- CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@](C3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
- Canonical SMILES
- CC(=O)O[C@H]1C(=O)[C@@]2(C)C([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
名称与同义词
- paclitaxel
- TAXOL
- Onxol
- Nov-Onxol
- Paclitaxel (Taxol)
- Paclitaxel - Taxol
- Taxol (Paclitaxel)
- Spectrum_001536
- AC1L9AVF
- CHEMBL48
- Spectrum2_000872
- Spectrum3_001057
- Spectrum4_001197
- Spectrum5_001491
- RefChem:1094655
- Probes2_000350
- Lopac0_001201
- BSPBio_001152
- BSPBio_002614
- KBioGR_000492
- KBioGR_001893
- KBioSS_000492
- KBioSS_002016
- 33069-62-4
- DivK1c_000441
- SCHEMBL788187
- SPECTRUM1503908
- SPBio_000943
- Pharmakon1600-01503908
- UPCMLD-DP108:001
- UPCMLD-DP108:002
- HMS501G03
- KBio1_000441
- KBio2_000492
- KBio2_002016
- KBio2_003060
- KBio2_004584
- KBio2_005628
- KBio2_007152
- KBio3_000903
- KBio3_000904
- KBio3_001834
- NINDS_000441
- Bio1_000362
- Bio1_000851
- Bio1_001340
- Bio2_000416
- Bio2_000896
- C47H51NO14
- GLXC-06669
- HMS1362J13
- HMS1792J13
- HMS1922K08
- HMS1990J13
- HMS2093K15
- HMS3412G15
- HMS3676G15
- AC-675
- CCG-40266
- NSC758645
- s1150
- AKOS015894977
- AKOS015960460
- LMPR0104390001
- LP01201
- NSC-758645
- SDCCGMLS-0066823.P001
- SDCCGSBI-0051168.P004
- SDCCGSBI-0051168.P012
- IDI1_000441
- IDI1_002171
- SMP1_000228
- NCGC00024995-02
- NCGC00024995-03
- NCGC00024995-04
- NCGC00024995-05
- NCGC00024995-06
- NCGC00024995-07
- NCGC00024995-08
- NCGC00024995-09
- NCGC00024995-10
- NCGC00024995-13
- NCGC00024995-18
- NCGC00024995-32
- NCGC00024995-43
- AS-11004
- BC201721
- BP-23960
- SBI-0051168.P003
- AB0008536
- EU-0101201
- NS00003967
- P1632
- J2.961.919K
- C07394
- T 7402
- AB00172230-03
- AB00172230_04
- AB00172230_05
- AO-378/21217001
- SR-01000597377
- SR-01000597377-1
- BRD-A28746609-001-02-4
- BRD-A28746609-001-04-0
- BRD-A28746609-001-05-7
- BRD-A28746609-001-10-7
- BRD-A28746609-001-11-5
- ,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b(2aH)-diyl diacetate
- ((1S,2S,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo(11.3.1.03,10.04,7)heptadec-13-en-2-yl) benzoate
- (1S,2S,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl benzoate
- (2aR,4S,4aS,6R,9S,11S,12S,12bS)-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-3,4,4a,5,6,9,10,11,12,12a-decahydro-1H-7
- (2R,3S)-2-Hydroxy-3-(benzoylamino)-3-phenylpropanoic acid (2R)-2beta,8alpha-diacetoxy-3-oxo-5beta,11alpha-dihydroxy-10alpha-(benzoyloxy)-4beta,14,15,15-tetramethyl-7beta,8-(epoxymethano)tricyclo[9.3.1.04,9]pentadecane-1(14)-ene-13alpha-yl ester
- [2aR-[2a?,4?,4a?,6?,9?(?R*,?S*),11?,12?,12a?,12b?]]-?-(Benzoylamino)-?-hydroxy-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester benzenepropanoic acid